Hyphens Pharma International Limited
Hyphens Pharma International Limited, often referred to as Hyphens Pharma, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Singapore (SG). Established in 2001, the company has made significant strides in providing innovative healthcare solutions across Asia, with a focus on specialty pharmaceuticals and consumer health products.
Hyphens Pharma is renowned for its unique portfolio, which includes prescription medicines, over-the-counter products, and nutraceuticals. The company distinguishes itself through strategic partnerships and a commitment to quality, ensuring that its offerings meet the highest standards of efficacy and safety. With a strong market position, Hyphens Pharma has achieved notable milestones, including expanding its operational reach and enhancing its product line to cater to diverse healthcare needs.
-8 vs industry average
Hyphens Pharma International Limited’s score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Hyphens Pharma International Limited?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Hyphens Pharma International Limited's reported carbon emissions
In 2025, Hyphens Pharma International Limited reported total emissions of approximately 406,900 kg CO2e, comprising 15,900 kg CO2e from Scope 1 emissions and 391,000 kg CO2e from Scope 2 emissions. The company has consistently disclosed its emissions data for the previous years, with 2024 emissions at approximately 470,200 kg CO2e and 2023 emissions at about 408,700 kg CO2e. Despite the fluctuations in emissions, Hyphens Pharma has not set specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or commitments to frameworks such as the Science Based Targets initiative (SBTi). The company has not reported any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. Hyphens Pharma's headquarters is located in Singapore (SG), and it operates with a commitment to transparency in its emissions reporting, although it currently lacks formal climate pledges or reduction initiatives.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Hyphens Pharma International Limited’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Hyphens Pharma International Limited yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
Hyphens Pharma International Limited
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project